Literature DB >> 26216891

IL-18 Is Involved in Eosinophil-Mediated Tumoricidal Activity against a Colon Carcinoma Cell Line by Upregulating LFA-1 and ICAM-1.

Solène Gatault1, Marie Delbeke2, Virginie Driss2, Aurore Sarazin2, Arnaud Dendooven2, Jean-Emmanuel Kahn3, Guillaume Lefèvre4, Monique Capron2.   

Abstract

Eosinophils are multifunctional leukocytes that are involved in innate and adaptive immune responses through the expression of various receptors and mediators. Previously, we showed that human eosinophils and T cells shared cytotoxic activities against tumor cells that involved the γ-δ TCR and cell-cell contact. In this study, we investigated the molecules involved in eosinophil-tumor cell interactions. Given the role of IL-18 in cell adhesion and in protecting against colon cancer, we evaluated its role in eosinophil-mediated cytotoxicity against Colo-205, a human colon carcinoma cell line. We found that human eosinophils exerted dose- and time-dependent tumoricidal activity against Colo-205 cells. Neutralization of IL-18 significantly reduced eosinophil-mediated Colo-205 apoptosis and inhibited cell-cell adhesion. Moreover, addition of rIL-18 led to upregulation of CD11a and ICAM-1 adhesion molecules, which were involved in the contact between eosinophils and Colo-205 cells. Our results indicated that IL-18 was involved in the eosinophil-mediated death of Colo-205 by facilitating contact between effector and target cells. These data underscored the involvement of an additional mediator in eosinophil-mediated antitumor cytotoxicity. Our findings support existing evidence that eosinophils could play a beneficial role in the context of colon cancer.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26216891     DOI: 10.4049/jimmunol.1402914

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

Review 1.  The contrasting roles of inflammasomes in cancer.

Authors:  Qin He; Yu Fu; Dean Tian; Wei Yan
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.

Authors:  Stefanie Gross; Michael Erdmann; Ina Haendle; Steve Voland; Thomas Berger; Erwin Schultz; Erwin Strasser; Peter Dankerl; Rolf Janka; Stefan Schliep; Lucie Heinzerling; Karl Sotlar; Pierre Coulie; Gerold Schuler; Beatrice Schuler-Thurner
Journal:  JCI Insight       Date:  2017-04-20

Review 3.  Synergy of Interleukin (IL)-5 and IL-18 in eosinophil mediated pathogenesis of allergic diseases.

Authors:  Hemanth Kumar Kandikattu; Sathisha Upparahalli Venkateshaiah; Anil Mishra
Journal:  Cytokine Growth Factor Rev       Date:  2019-05-10       Impact factor: 7.638

Review 4.  Eosinophils: The unsung heroes in cancer?

Authors:  Gilda Varricchi; Maria Rosaria Galdiero; Stefania Loffredo; Valeria Lucarini; Giancarlo Marone; Fabrizio Mattei; Gianni Marone; Giovanna Schiavoni
Journal:  Oncoimmunology       Date:  2017-11-13       Impact factor: 8.110

5.  Newly divided eosinophils limit ozone-induced airway hyperreactivity in nonsensitized guinea pigs.

Authors:  Sarah A Wicher; David B Jacoby; Allison D Fryer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-03-03       Impact factor: 5.464

Review 6.  A new dawn for eosinophils in the tumour microenvironment.

Authors:  Sharon Grisaru-Tal; Michal Itan; Amy D Klion; Ariel Munitz
Journal:  Nat Rev Cancer       Date:  2020-07-16       Impact factor: 60.716

7.  The Peripheral Blood Eosinophil Proteome.

Authors:  Emily M Wilkerson; Mats W Johansson; Alexander S Hebert; Michael S Westphall; Sameer K Mathur; Nizar N Jarjour; Elizabeth A Schwantes; Deane F Mosher; Joshua J Coon
Journal:  J Proteome Res       Date:  2016-04-01       Impact factor: 4.466

8.  HuR Small-Molecule Inhibitor Elicits Differential Effects in Adenomatosis Polyposis and Colorectal Carcinogenesis.

Authors:  Michaela Lang; David Berry; Katharina Passecker; Ildiko Mesteri; Sabin Bhuju; Florian Ebner; Vitaly Sedlyarov; Rayko Evstatiev; Kyle Dammann; Alexander Loy; Orest Kuzyk; Pavel Kovarik; Vineeta Khare; Martin Beibel; Guglielmo Roma; Nicole Meisner-Kober; Christoph Gasche
Journal:  Cancer Res       Date:  2017-02-20       Impact factor: 12.701

Review 9.  AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer.

Authors:  E Jensen-Jarolim; H J Bax; R Bianchini; S Crescioli; T R Daniels-Wells; D Dombrowicz; E Fiebiger; H J Gould; S Irshad; J Janda; D H Josephs; F Levi-Schaffer; L O'Mahony; G Pellizzari; M L Penichet; F Redegeld; F Roth-Walter; J Singer; E Untersmayr; L Vangelista; S N Karagiannis
Journal:  Allergy       Date:  2017-10-05       Impact factor: 13.146

10.  Eosinophilic inflammation promotes CCL6-dependent metastatic tumor growth.

Authors:  Fei Li; Xufei Du; Fen Lan; Na Li; Chao Zhang; Chen Zhu; Xiaohui Wang; Yicheng He; Zhehua Shao; Haixia Chen; Man Luo; Wen Li; Zhihua Chen; Songmin Ying; Huahao Shen
Journal:  Sci Adv       Date:  2021-05-26       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.